Your Face Could Reveal if You Have a Rare Disease

April 30, 2017

WIRED 

“FDNA provides an app called Face2Gene to clinicians, free of charge. After a photo of the patient is taken, the app uses facial analysis and artificial intelligence to analyze the relevant features of the patient and compare them with a crowd-sourced database of tens of thousands, providing the clinician with a narrow list of possible rare diseases within seconds.”

 

The article highlights FDNA’s breakthrough technology in expediting diagnosis and reducing the cost of care for developmental and genetic disorders. Face2Gene, an AI-driven platform, employs facial recognition to analyze patient photos and identify distinct markers of over 2,000 rare genetic disorders. This innovative decision support tool streamlines the diagnostic process, providing healthcare professionals with faster, more accurate preliminary assessments. The article emphasizes the transformative potential of Face2Gene in improving diagnostic accuracy and patient outcomes, especially in areas with limited access to genetic specialists. FDNA’s technology represents a significant advancement in the early detection and treatment of rare diseases.

Related articles

Dr. Bruno

The Importance of Teaching Face2Gene to Pediatricians

In the world of rare genetic diseases, early diagnosis is often the key to better patient outcomes. However, the diagnostic journey can be long and complex, sometimes taking years before a definitive answer is found. Dr. Bruno Bordest, a Brazilian geneticist who teaches at the Universidade Federal de Mato Grosso, has been working to bridge […]

Continue reading
AI in genetic diagnosis

The Evolution of FDNA’s technology: An Interview with Aviram Bar Haim

Analyzing facial features has long been a vital step in diagnosing genetic syndromes. In recent years, AI-driven technologies have transformed this process, making it more efficient and accurate. Leading this innovation is Face2Gene, an advanced AI platform that leverages machine learning to assist clinicians in identifying genetic disorders. To explore the development of this groundbreaking […]

Continue reading